Oncotarget

Vol 10, No 10

February 1, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 10 of Oncotarget features Figure 6, "Model of the role of LATS1/2 kinases in the pre–self-renewal (pre-SR) stage during sphere formation by CSCs," by Nozaki, et al.

Table of Contents

Priority Research Papers

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer

https://doi.org/10.18632/oncotarget.26583

Masami Nozaki, Norikazu Yabuta, Moe Fukuzawa, Satomi Mukai, Ayumi Okamoto, Towa Sasakura, Kohshiro Fukushima, Yoko Naito, Gregory D. Longmore,  and Hiroshi Nojima
1014-1030
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Research Papers

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft

https://doi.org/10.18632/oncotarget.26613

Siddesh V. Hartimath, Ayman El-Sayed, Amal Makhlouf, Wendy Bernhard, Carolina Gonzalez, Wayne Hill, Angel Casaco Parada, Kris Barreto, Clarence Ronald Geyer,  and Humphrey Fonge
1031-1044
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases

Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases

https://doi.org/10.18632/oncotarget.26620

Fabrice Lucien, Vivian Lac, Daniel D. Billadeau, Ayelet Borgida, Steven Gallinger,  and Hon S. Leong
1045-1055
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells

https://doi.org/10.18632/oncotarget.26621

Austin R. Dosch, Xizi Dai, Alexander A. Gaidarski III, Chanjuan Shi, Jason A. Castellanos, Michael N. VanSaun, Nipun B. Merchant,  and Nagaraj S. Nagathihalli
1056-1069
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study

https://doi.org/10.18632/oncotarget.26626

Takatsugu Ogata, Hironaga Satake, Misato Ogata, Yukimasa Hatachi, Hayato Maruoka, Daisuke Yamashita, Hiroki Hashida, Madoka Hamada,  and Hisateru Yasui
1070-1084
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Andrographolide induces DNA damage in prostate cancer cells

Andrographolide induces DNA damage in prostate cancer cells

https://doi.org/10.18632/oncotarget.26628

Ingrid S. Forestier-Román, Andrés López-Rivas, María M. Sánchez-Vázquez, Krizia Rohena-Rivera, Gretchen Nieves-Burgos, Humberto Ortiz-Zuazaga, Carlos A. Torres-Ramos,  and Magaly Martínez-Ferrer
1085-1101
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo

Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo

https://doi.org/10.18632/oncotarget.26634

Marcia Convento, Edson Pessoa, Alef Aragão, Nestor Schor,  and Fernanda Borges
1102-1118
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

The correlation of p22phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma

The correlation of p22phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma

https://doi.org/10.18632/oncotarget.26637

Masayuki Kobayashi, Ryoko Saito, Yasuhiro Miki, Ren Nanamiya, Chihiro Inoue, Jiro Abe, Ikuro Sato, Yoshinori Okada,  and Hironobu Sasano
1119-1131
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer

Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer

https://doi.org/10.18632/oncotarget.26638

Malamati Kourti, Andrew Westwell, Wen Jiang,  and Jun Cai
1132-1148
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies

https://doi.org/10.18632/oncotarget.26646

Yoshinori Ino, Seiji Oguro, Rie Yamazaki-Itoh, Shutaro Hori, Kazuaki Shimada,  and Nobuyoshi Hiraoka
1149-1159
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma

https://doi.org/10.18632/oncotarget.26647

Yoshiaki Abe, Tetsuya Kobayashi, Yoshiaki Usui, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi,  and Kosei Matsue
1160-1170
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC